We serve Chemical Name:1,3-Dichloro-7-fluoroisoquinoline CAS:941294-25-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1,3-Dichloro-7-fluoroisoquinoline
CAS.NO:941294-25-3
Synonyms:1,3-Dichloro-7-fluoroisoquinoline
Molecular Formula:C9H4Cl2FN
Molecular Weight:216.03900
HS Code:2933499090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:332.3ºC at 760 mmHg
Density:1.491 g/cm3
Index of Refraction:1.636
PSA:12.89000
Exact Mass:214.97000
LogP:3.68070
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1,3-Dichloro-7-fluoroisoquinoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,3-Dichloro-7-fluoroisoquinoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,3-Dichloro-7-fluoroisoquinoline Use and application,1,3-Dichloro-7-fluoroisoquinoline technical grade,usp/ep/jp grade.
Related News: Grégoire Boutonnet, Chief Operating Officer of NOVA, said: “I am thrilled to be joining the NOVA team at this exciting period of growth as we launch the Jinkō platform towards wider adoption in the clinical trial development space. 1H-Pyrazole-3-carboxylic acid, 1-[(4-bromophenyl)methyl]-, ethyl ester manufacturers CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. 1-Piperidineacetamide, 4-[(4-fluorophenyl)methyl]-N-(4-hydroxyphenyl)- suppliers Improved gene mining techniques have permitted previously uncharacterized gene clusters to be discovered, while advances in heterologous expression and production have allowed the encoded enzymes to rapidly be scaled up and evaluated as tools for organic synthesis. 1-((5-(5-chlorothiophen-2-yl)isoxazol-3-yl)methyl)-N-(1-isopropylpiperazin-2-yl)-1H-indole-2-carboxamide 2,2,2-trifluoroacetate vendor & factory The incredible selectivity of enzyme catalysts consequently simplifies workflows by generating fewer by-products and reducing impurities to markedly decrease the total number of synthetic steps required.,CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication.
